The treatment of intestinal amebiasis with magnamycin.

The treatment of intestinal amebiasis with magnamycin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The treatment of intestinal amebiasis with magnamycin. Abstract Text:

H SENECA,

The treatment of intestinal amebiasis with magnamycin. Publishing Authors By Initials

H SENECA,

For similar parasitic diseases: intestinal diseases, parasitic: dysentery, amebic research abstracts see: parasitic diseases: intestinal diseases, parasitic: dysentery, amebic research

PUBMED ID PMID:

MEDLINE DATE:

The treatment of intestinal amebiasis with magnamycin. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: American practitioner and digest of treatment

VOLUME: 5

Page Numbers: 930-31

Journal Abbreviation:

ISSN:

DAY: 24

MONTH: Dec

YEAR: 1954

The treatment of intestinal amebiasis with magnamycin. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 14840350

The treatment of intestinal amebiasis with magnamycin. Keywords Mesh Terms:

KEYWORDS: Dysentery, Amebic

MESH TERMS: therapy

Chemical & Substance for Abstract: The treatment of intestinal amebiasis with magnamycin. Information

Substance Name: carbomycin

Registry Number: 4564-87-8

Grant and Affiliation Information for The treatment of intestinal amebiasis with magnamycin.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am Pract Dig Treat

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The treatment of intestinal amebiasis with magnamycin Related Publications

• A MANNITOL-PECTIN-FRUIT JUICE PREPARATION (MANIGEL) WITH MILD LAXATIVE ACTION.
• Aerobacter aerogenes bacteremia and bacilluria.
• Aminoacridinium hexylresorcinolate, a new antimicrobial agent.
• Androgens and renal function; effect of testosterone propionate in uremia due to cholera.
• Bacterial mutation and the evolution of drug resistance in relation to chemotherapy.
• Bacterial urease inhibition chemotherapy in drug resistant infections.
• Biological effects and subsequent economic effects and losses from marine pollution and degradations in marine environments: Implications from the literature.
• CURRENT THERAPY OF INFECTIONS OF THE RENAL EXCRETORY SYSTEM.
• Diarrhea and its management, with special reference to polycarbophil-thihexinol-neomycin therapy.
• Endotoxic shock and hyperpyrexia in urological practice.
• Etiology and treatment of diarrheas.
• Influenza: epidemiology, etiology, immunization and management.
• Management of Aerobacter and Escherichia in urinary tract infections.
• Management of infections and infestations in the elderly.
• Phthalyl sulfacetimide in ulcerative colitis.
• Pyelonephritis--clinical and experimental.
• Relative efficacy of carbenicillin indanyl sodium and of trimethoprim/sulfamethoxazole in urinary-tract infections.
• Rheumatoid arthritis complicated by severe ulcerative colitis, successfully treated with prednisone and Rauwolfia: a case history.
• Sterilization of the human gut with phthalylsulfacetimide.
• Sulfameter in clinical medicine.
• Sulfamethoxypyrazine in the treatment of urinary-tract infections.
• The current status of pyelonephritis.
• The treatment of intestinal amebiasis with magnamycin.
• Urinary-tract infections: etiology, microbiology, pathophysiology, diagnosis and management.